
    
      To characterize glycolytic metabolism in patients as demonstrated in leukemic cells and serum
      metabolite analysis after C13-glucose administration at strategic time points of treatment.

      To detect and measure 13C-labeled metabolic markers which may be present in the serum and
      urine of leukemic patients.

      To characterize glycolytic metabolism in patients as demonstrated in leukemic cells and serum
      metabolite analysis after C13-glucose administration at strategic time points of treatment.

      To detect and measure 13C-labeled metabolic markers which may be present in the serum and
      urine of leukemic patients.
    
  